Reducing death from cervical cancer examining the prevention paradigms.
The prevention of morbidity and mortality from cervical cancer will hinge upon our understanding of the epidemiology, the molecular basis, and natural history of the disease and its associated precursors. This article serves as an introduction and presents our current challenge to prevent or find all women at risk, and alter the course of disease to effect a regression or a cure.
Lonky
Neal M
NM
Department of Obstetrics and Gynecology, Kaiser Permanente, Anaheim, California 92801, USA.
D019049:Developed Countries; D003906:Developing Countries; D005260:Female; D006297:Health Services Accessibility; D006801:Humans; D015994:Incidence; D008403:Mass Screening / Q000379:methods*; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000517:prevention & control; D014412:Tumor Virus Infections / Q000517:prevention & control; D014481:United States / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000517:prevention & control* / Q000821:virology